2015
DOI: 10.1378/chest.14-2954
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Billing Review of Extracorporeal Membrane Oxygenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 31 publications
0
10
0
Order By: Relevance
“…32 Previously reported survival rates to hospital discharge range from 29 to 47%, including the large Extracorporeal Life Support Organization (ELSO) registry report of 4200 ECPR patients. 6,33,34 Given that this review is based largely on existing case reports, case series or small observational studies, heterogeneity was evidenced in both populations and interventions. There is variability in patient selection, age limits, duration of no-flow, the moment when the OHCA is considered refractory to conventional resuscitation, logistics and clinical pathways, time from cardiac arrest to cannulation, interventions deployed, and levels of care provided before and after ROSC.…”
Section: Discussionmentioning
confidence: 99%
“…32 Previously reported survival rates to hospital discharge range from 29 to 47%, including the large Extracorporeal Life Support Organization (ELSO) registry report of 4200 ECPR patients. 6,33,34 Given that this review is based largely on existing case reports, case series or small observational studies, heterogeneity was evidenced in both populations and interventions. There is variability in patient selection, age limits, duration of no-flow, the moment when the OHCA is considered refractory to conventional resuscitation, logistics and clinical pathways, time from cardiac arrest to cannulation, interventions deployed, and levels of care provided before and after ROSC.…”
Section: Discussionmentioning
confidence: 99%
“…The indications for initiating ECMO usually mirror those reported in the CEASAR trail, ie PaO 2 : FiO 2  < 80, Plateau pressures > 35 mm Hg, FiO 2  > 90%, pH < 7.2 with uncompensated hypercarbia in a patient with a reversible disease [10, 11]. In the setting of isolated respiratory failure, V-V ECMO helps provide either complete or partial support of the lungs when cardiac output is sufficient.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the similar severity, we could have significantly improved the survival rate. Recent advances in technology (e.g., biocompatible artificial membranes, heparin-coated circuits, and smaller devices), and network organization with referral ECMO centers have contributed to the dramatic increase in the use of ECMO [ 12 , 13 ]. However, despite these technological improvements, ECMO is still associated with many complications including bleeding, thrombosis, and nosocomial infection [ 14 – 16 ].…”
Section: Discussionmentioning
confidence: 99%